Support and Outreach to Increase Screening for Lung Cancer in Patients With a History of Smoking

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50-77
SponsorRonald Myers

About this trial

This clinical trial tests how well providing education improves screening for lung cancer in patients with a history of smoking. Screenings may help doctors find lung cancer sooner when it may be easier to treat. Education and counseling may be an effective method to help providers and patients learn about lung cancer screening. Providing education and decision counseling to providers and patients may increase lung cancer screening.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Primary care practice (family medicine, geriatrics, internal medicine) in one of the 4 participating health systems

Practice using the main electronic medical record (EMR) of each system, in order to run appropriate patient recruitment reports

Practice with at least 50% of practice providers (physicians and advanced care providers) consenting to participate

Have an office or telemedicine established patient visit scheduled with a primary care provider in one of the participating practices within next 14 to 25 days

Disqualifiers

Any lung computed tomography (CT) or low-dose computed tomography (LDCT) scan in the past 11 months, current procedural terminology (CPT) Codes are as follows

G0297 - LDCT screening

71250 - CT w/o contrast

71260 - CT w/ contrast

Trial design

Design model

Factorial

Treatments tested in this trial

  • Survey Administration

    Other intervention

    Complete survey

  • Educational Activity

    Other intervention

    Undergo online shared decision making training and distance learning

  • Survey Administration

    Other intervention

    Complete survey

  • Electronic Health Record Review

    Other intervention

    Undergo electronic health record review

  • Educational Activity

    Other intervention

    Undergo online shared decision making training and distance learning

  • Counseling

    Other intervention

    Undergo shared decision making counseling

  • Survey Administration

    Other intervention

    Complete survey

  • Electronic Health Record Review

    Other intervention

    Undergo electronic health record review

Treatment groups

822 Participants
are divided into 4 treatment groups
Group A: Group A (Providers): (survey, online educational activity)Experimental treatment 2 interventions
Group B: Group B (Providers): (survey)Active comparator 1 intervention
Group C: Group A (Patients): (EHR, educational activity, counseling))Experimental treatment 3 interventions
Group D: Group B (Patients): (survey)Active comparator 2 interventions

Trial outcomes

Primary outcomes

1

Completion of initial lung cancer screening (LCS)

LCS will be assessed through an endpoint electronic medical records (EMR) search, supplemented with a question on the participant endpoint survey to capture any LCS performed outside the health system and/or not captured in the EMR.

Time frame
Within 4 months of randomization

Secondary outcomes

1

Referral for LCS

Referrals for lung cancer screenings will be found by reviewing electronic medical records.

Time frame
Up to 5 years
2

Tobacco cessation services

Referrals for tobacco treatment services will be found by reviewing medical records.

Time frame
Up to 5 years
3

Repeat annual lung cancer screenings within 11-16 months of original screening

Number of repeat screenings will be found by reviewing electronic medical records.

Time frame
within 11-16 months of original screening
4

Diagnostic follow up after initial lung cancer screening

Number of patients that had follow up within 4 months of initial lung cancer screening will be found by reviewing electronic medical records.

Time frame
Up to 4 months of screening

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Ronald Myers

Lead sponsor

Thomas Jefferson University

Sponsor institution

National Cancer Institute (NCI)

Collaborator